Liberty Biopharma
0
0
+C$0.00+0% 00:00 Today
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Liberty Biopharma Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease. The company was formerly known as Avagenesis Corp. and changed its name to Liberty Biopharma Inc. in January 2017. Liberty Biopharma Inc. is based in Richmond, Canada.
Show More
CEO
Country
Canada
ISIN
CA5302821023
Listings
0 Comments
Share your thoughts
FAQs
What is Liberty Biopharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on TSX Venture Exchange exchange Liberty Biopharma stocks are traded under the ticker LTY.V.
In which sector is Liberty Biopharma located?▼
Liberty Biopharma operates in the Materials sector.
When did Liberty Biopharma complete a stock split?▼
The last stock split for Liberty Biopharma was on July 23, 2018 with a ratio of 1:15.